ScopeManchester University NHS Foundation Trust
92 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
North West Genomic Laboratory Hub (Manchester) and Willink Biochemical Genetics Laboratory, Manchester Centre for Genomic Medicine, St Mary's Hospital, Oxford Road
Manchester M13 9WL , United Kingdom
Manchester M13 9WL , United Kingdom
Accreditation
Active
UKAS
9865
mft.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
9865
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Wythenshawe Hospital
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Liverpool
Manchester University NHS Foundation Trust
Wythenshawe
Test Capabilities (92)
| Standard Reference | Description | Category |
|---|---|---|
| 7-Dehydrocholesterol | EDTA plasma, serum | 7-Dehydrocholesterol | Clinical Chemistry |
| Detection of the Following: Acid and Neutral Mucins | Detection of the following: | Special Staining using in house | Histopathology / Cytology |
| TPMT | TPMT | Molecular Diagnostics / PCR |
| Acyl carnitines and free carnitine | Acyl carnitines and free carnitine | Other |
| Alpha thalassemia (HBA1 and HBA2) | Alpha thalassemia (HBA1 and HBA2) | Other |
| Amino acid quantitation | Amino acid quantitation | Other |
| Arylsulphatase A (Metachromatic leukodystrophy) | Arylsulphatase A (Metachromatic leukodystrophy) | Other |
| Arylsulphatase B (MPS VI, Maroteaux-Lamy) | Arylsulphatase B (MPS VI, Maroteaux-Lamy) | Other |
| Aspartylglucosaminidase (Aspartylglucosaminuria) | Aspartylglucosaminidase (Aspartylglucosaminuria) | Other |
| Beta globin gene cluster deletions | Beta globin gene cluster deletions | Other |
| Beta thalassemia (HBB and HBG2 promoter region) | Beta thalassemia (HBB and HBG2 promoter region) | Other |
| Beutler screening test for classical galactosaemia (galactose-1- phosphate uridyl transferase) | Beutler screening test for classical galactosaemia (galactose-1- phosphate uridyl transferase) | Other |
| Biochemical genetics examination for the purposes of clinical diagnosis | Biochemical genetics examination for the purposes of clinical diagnosis | Other |
| Breast and Ovarian cancer (BRCA1 and 2) | Breast and Ovarian cancer (BRCA1 and 2) | Other |
| Breast and Ovarian cancer (BRCA1 and BRCA2) | Breast and Ovarian cancer (BRCA1 and BRCA2) | Other |
| Cell culture for cryogenic storage, DNA/RNA extraction, export or immortalisation (lymphoblastoid cell lines) | Cell culture for cryogenic storage, DNA/RNA extraction, export or immortalisation (lymphoblastoid cell lines) | Other |
| Chitotriosidase | Chitotriosidase | Other |
| Chromosome analysis for : Prenatal Diagnosis | Chromosome analysis for: Developmental disorders | Other |
| Colorectal cancer (MLH1 hypermethylation and BRAF codon 600) | Colorectal cancer (MLH1 hypermethylation and BRAF codon 600) | Other |
| Copy Number Variations (CNVs) | Copy Number Variations (CNVs) | Other |
| Cystic Fibrosis (CFTR) | Cystic Fibrosis (CFTR) | Other |
| Cytogenetics examination for the purposes of clinical diagnosis | Cytogenetics examination for the purposes of clinical diagnosis | Other |
| DNA extraction and quality check for subsequent in house analysis (see below), referral to specialist centres and longterm storage | DNA extraction and quality check for subsequent in house analysis (see below), referral to specialist centres and longterm storage | Other |
| Decanoylcarnitine | Decanoylcarnitine | Other |
| Detection of F8 intron 1 gene inversion mutation | Detection of F8 intron 1 gene inversion mutation | Other |
| Detection of mutations | Detection of mutations | Other |
| Detection of other Metabolic disorders: Amino acid screen | Detection of other Metabolic disorders: Amino acid screen | Other |
| Detection of plasma and white cell lysosomal storage enzymes : b-mannosidase (beta Mannosidosis) a-N-acetylglucosaminidase (MPS III B/ Sanfilippo III B disease) a-galactosidase (Fabry disease) confirmatory | Detection of plasma and white cell lysosomal storage enzymes: Acid esterase (liposomal acid lipase) Wolman Disease/ CESD/ LAL-D a-fucosidase (Fucosidosis) b-galactosidase (GM 1 gangliosidosis/ MPS IV B/ Morquio B/ Galactosialidosis b-glucosidase (Gaucher disease) b-glucuronidase (MPS VII, Sly disease) a-iduronidase (Hurler disease / MPS I/ Scheie disease) a-glucosidase (Pompe) confirmatory Galactocerebrosidase (screen) Krabbe leukodystrophy N-acetyl-a-galactosaminidase (Schindler disease) NCL screen (neuronal ceroid lipofuscinosis/ Batten's) b-hexosaminidase A (Tay-Sachs disease) b-hexosaminidase A & B (Sandhoff's disease) a-mannosidase (alpha Mannosidosis) | Other |
| Detection of single nucleotide polymorphism of: Prothrombin G20210A | Detection of single nucleotide polymorphism of: Prothrombin G20210A | Other |
| Detection of stored cholesterol(Niemann-Pick Type C) a-glucosidase CRIM (Pompe) | Detection of stored cholesterol(Niemann-Pick Type C) a-glucosidase CRIM (Pompe) | Other |
| Detection of the following gene mutations: F5 | Detection of the following gene mutations: F5 | Other |
| Detection of whole or partial gene deletions and duplications and probe specific mutations of the following genes/disease regions: Angelman syndrome/ Prader-Willi Syndrome (UBE3A, SNRPN) | Detection of whole or partial gene deletions and duplications and probe specific mutations of the following genes/disease regions: Angelman syndrome/ Prader-Willi Syndrome (UBE3A, SNRPN) | Other |
| Detection of whole or partial gene deletions and duplications: Alpha globin gene cluster deletions | Detection of whole or partial gene deletions and duplications: Alpha globin gene cluster deletions | Other |
| FV Leiden | FV Leiden | Other |
| Familial Adenomatous Polyposis (APC) (FAP) and MUTYH- Associated Polyposis (MUTYH) (MAP) | Familial Adenomatous Polyposis (APC) (FAP) and MUTYH- Associated Polyposis (MUTYH) (MAP) | Other |
| Fragile X Syndrome and associated disorders (FXTAS and FXPOI) (FMR1) | Fragile X Syndrome and associated disorders (FXTAS and FXPOI) (FMR1) | Other |
| Glioma (KIAA1549: BRAF fusion, C11orf95: RELA fusion, EGFRvIII transcript) | RNA from FFPE samples Glioma (KIAA1549: BRAF fusion, | DOC4253, DOC4344^, DOC4206 | Other |
| Glioma (MGMT hypermethylation and BRAF codon 600) | Glioma (MGMT hypermethylation and BRAF codon 600) | Other |
| Glutarylcarnitine | Glutarylcarnitine | Other |
| Graft v Host determination following bone marrow transplant | Graft v Host determination following bone marrow transplant | Other |
| HFE C282Y/H63D | HFE C282Y/H63D | Other |
| Heparan sulphamidase (MPS III A, Sanfilippo A) | Heparan sulphamidase (MPS III A, Sanfilippo A) | Other |
| Identity testing | Identity testing | Other |
| Iduronate sulphatase (Hunter disease/ MPS II) a-galactosidase (Fabry disease) screen a-glucosidase (Pompe) screen | Iduronate sulphatase (Hunter disease/ MPS II) a-galactosidase (Fabry disease) screen a-glucosidase (Pompe) screen | Other |
| Indels | Indels | Other |
| Isovalerylcarnitine | Isovalerylcarnitine | Other |
| Leucine | Leucine | Other |
| Lynch Syndrome (HNPCC, familial colorectal cancer) (MLH1, MSH2, MSH6) | Lynch Syndrome (HNPCC, familial colorectal cancer) (MLH1, MSH2, MSH6) | Other |
| MCADD common mutation (ACADM) | MCADD common mutation (ACADM) | Other |
| MGMT methylation analysis (Giloma) | MGMT methylation analysis (Giloma) | Other |
| MLH1 promoter hypermethylation (MLH1) | MLH1 promoter hypermethylation (MLH1) | Other |
| Maternal contamination testing | Maternal contamination testing | Other |
| Meningiomas (SMARCE1) | Meningiomas (SMARCE1) | Other |
| Methionine | Methionine | Other |
| Molecular Haematology examinations for the purposes of clinical diagnosis | Molecular Haematology examinations for the purposes of clinical diagnosis | Other |
| Molecular Oncology examinations for the purposes of clinical diagnosis | Molecular Oncology examinations for the purposes of clinical diagnosis | Other |
| Molecular genetics examination for the purposes of clinical diagnosis | Molecular genetics examination for the purposes of clinical diagnosis | Other |
| Mucopolysaccharide urine screen | Mucopolysaccharide urine screen | Other |
| Multiple hydrolases (I-cell disease/ mucolipidosis II/III) screen. [battery composition depends on sample type] | Multiple hydrolases (I-cell disease/ mucolipidosis II/III) screen. [battery composition depends on sample type] | Other |
| Multiple sulphatases (multiple sulphatase deficiency) [composition can comprise any of several sulphatases] | Multiple sulphatases (multiple sulphatase deficiency) [composition can comprise any of several sulphatases] | Other |
| Mutation detection for the purpose of clinical diagnosis, carrier detection and predictive testing in the following: Angelman Syndrome/ Prader-Willi Syndrome (UBE3A, SNRPN) | Mutation detection for the purpose of clinical diagnosis, carrier detection and predictive testing in the following: Angelman Syndrome/ Prader-Willi Syndrome (UBE3A, SNRPN) | Other |
| Mutation detection of sequence variants causing genetic diseases and disorder: Single Nucleotide Variants (SNVs) | Mutation detection of sequence variants causing genetic diseases and disorder: Single Nucleotide Variants (SNVs) | Other |
| Neurofibromatosis type 1 (NF1) | Neurofibromatosis type 1 (NF1) | Other |
| Neurofibromatosis type 2 (NF2) | Neurofibromatosis type 2 (NF2) | Other |
| Neurofibromatosis type 2 (NF2; incl. LOH) | Neurofibromatosis type 2 (NF2; incl. LOH) | Other |
| Newborn Screening (IMD): C5 isobars | Newborn Screening (IMD): Phenylalanine | Other |
| Octanoylcarnitine | Octanoylcarnitine | Other |
| Oligosaccharide/ sialic acid screen | Oligosaccharide/ sialic acid screen | Other |
| Oxysterol | Oxysterol | Other |
| PKU monitoring | PKU monitoring | Other |
| Phytanic acid and Pristanic acid | Phytanic acid and Pristanic acid | Other |
| Pigmentosa R33 (RPGR, exon ORF15 only) | Pigmentosa R33 (RPGR, exon ORF15 only) | Other |
| Plasmalogens | Plasmalogens | Other |
| Possible X-linked Retinitis | Possible X-linked Retinitis | Other |
| Prenatal/Postnatal diagnosis of aneuploidy (chromosomes 13, 18, 21 or sex chromosomes) | Prenatal/Postnatal diagnosis of aneuploidy (chromosomes 13, 18, 21 or sex chromosomes) | Other |
| Quantitative detection of Creatinine | Quantitative detection of Creatinine | Other |
| Quantitative detection of clinically relevant nucleic acid sequence variants for the following: Non-Small Cell Lung Cancer (somatic mutations, - tumour samples) (EGFR) | Quantitative detection of clinically relevant nucleic acid sequence variants for the following: Non-Small Cell Lung Cancer (somatic mutations, - tumour samples) (EGFR) | Other |
| Quantitative monitoring of gene expression for: RUNX1/RUNX1T1 PML::-RARA (t15;17) CBFB::-MYH11 nv(16) and t16;16) NPM1 | Quantitative monitoring of gene expression for: RUNX1/RUNX1T1 PML::-RARA (t15;17) CBFB::-MYH11 nv(16) and t16;16) NPM1 | Other |
| RNA extraction and quality check for subsequent in house analysis (see below), referral to specialist centres and longterm storage | RNA extraction and quality check for subsequent in house analysis (see below), referral to specialist centres and longterm storage | Other |
| Retinoblastoma (RB1) | Retinoblastoma (RB1) | Other |
| Rhabdoid Tumour (SMARCB1/ LZTR1) | Rhabdoid Tumour (SMARCB1/ LZTR1) | Other |
| Schwannomatosis (LZTR1, SMARCB1) | Schwannomatosis (LZTR1, SMARCB1) | Other |
| Schwannomatosis; Atypical Familial | Schwannomatosis; Atypical Familial | Other |
| Sphingomyelinase (Niemann Pick type A/B, acid sphingomyelinase deficiency, ASMD) | Sphingomyelinase (Niemann Pick type A/B, acid sphingomyelinase deficiency, ASMD) | Other |
| Succinylacetone | Succinylacetone | Other |
| Succinylacetone (to investigate tyrosinameia type 1) | Succinylacetone (to investigate tyrosinameia type 1) | Other |
| Sugar Chromatography | Sugar chromatography | Other |
| Sulphite | Sulphite | Other |
| Testing | Testing | Other |
| Total Homocysteine | Total homocysteine | Other |
| Tyrosine | Tyrosine | Other |
| Very Long Chain Fatty Acids | Very Long Chain Fatty Acids | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.